中源协和(600645.SH)拟收购上海中源济生公司25%股权

Core Viewpoint - Zhongyuan Union (600645.SH) aims to enhance operational decision-making efficiency by acquiring a 25% stake in Shanghai Zhongyuan Jisheng Cell Technology Co., Ltd. from Shanghai Yanlin Biotechnology Co., Ltd. for RMB 3.8196 million, thereby making it a wholly-owned subsidiary [1] Group 1: Acquisition Details - The acquisition price for the 25% stake is RMB 3.8196 million [1] - Post-transaction, Shanghai Zhongyuan Jisheng will become a wholly-owned subsidiary of Zhongyuan Union [1] Group 2: Strategic Implications - The transaction is expected to improve operational decision-making efficiency and leverage existing resources such as the cell life experience center and established market channels [1] - The integration aims to enhance collaboration across various business segments and build a complete business loop for adult health cell storage in the East China region [1]